Advertise With UsAdvertise on our extensive network of industry websites and newsletters.
Get the PBR newsletterSign up to our free email to get all the latest PBR
news.Reliant seeks approval of Omacor plus statin therapy
As part of this filing, Reliant submitted new data from the recently completed trial that evaluated the efficacy and safety of Omacor as an adjunct to diet and
As part of this filing, Reliant submitted new data from the recently completed trial that evaluated the efficacy and safety of Omacor as an adjunct to diet and
Abbott’s cash tender offer to purchase all of the outstanding common stock of Kos expired on December 12, 2006. Abbot offered to acquire Kos last month for $3.7
Barr is seeking authorization to market a generic version of Thalomid 200mg tablets in the US. Celgene has approval to market Thalomid as a treatment in combination with
The new drug application includes the results of the company's phase III clinical program as well as the results of additional phase I and phase II studies. Indevus
GTS-21 has demonstrated memory and cognition enhancement activity in human clinical trials. GTS-21 has been studied in multiple phase I studies in healthy volunteers and one phase I/II
This will be the first phase III study to investigate whether adjuvant treatment with Tykerb will improve disease-free survival in women with early-stage HER2 breast cancer, including those
The company believes Oxytrex offers less physical dependence and withdrawal than oxycodone, the prescription painkiller widely used to treat persistent severe chronic pain. This study is evaluating patients
Provision of the additional information will allow the FDA to determine the comparability of the new data to that contained within the original Trexima new drug application and
The phase I study will be conducted using single and multiple oral doses with the objective of assessing safety and bioavailability of GRC 6211 in healthy human beings.
Before entering into this agreement Lonza and Solvay already had an ongoing commercial partnership. As part of the manufacturing alliance Lonza will produce an important selection of Solvay's